Pertuzumab (P) as ≥ second-line therapy for HER2-positive metastatic breast cancer (mBC): Swiss clinical experience

Pertuzumab (P) as ≥ second-line therapy for HER2-positive metastatic breast cancer (mBC): Swiss clinical experience

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 30; p. iii57
Main Authors: Biskup, E.M., Montavon Sartorius, C., Müller, A., Leo, C., Uhlmann Nussbaum, C., Koychev, D., Schreiber, A., Taverna, C., Thorn, D., Vetter, M.
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-05-2019
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdz100.028